OTC Markets OTCQB • USD
NervGen Pharma Corp. (NGENF)
At close: June 7 at 3:36 PM EDT
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview
Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index
Return | NGENF | S&P/TSX Composite index |
---|---|---|
YTD | -28.43% | +5.00% |
1-Year | +15.14% | +9.73% |
3-Year | +21.06% | +9.87% |